Single-Cell Phenotypic Analysis: Breaking the Law of Averages

The Scientist is bringing together a panel of experts to share their experience with single-cell phenotypic analysis and to reflect on the clarity it provides. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

By | February 15, 2017

FREE Webinar

Wednesday, March 29, 2017
2:30 - 4:00 p.m. EDT
View the Video Now

Population-scale cellular analysis has provided many valuable insights into general trends of cell behavior and expression, but rare and low-level events can get lost in the lysate. Averaging the signals from an entire culture can drown out the least prevalent but most important phenotypes. That’s why single-cell analysis has made such an impact, enabling higher throughputs, rare-event detection, and more-precise and meaningful analyses. To explore this exciting new frontier, The Scientist is bringing together a panel of experts to share their experience with single-cell phenotypic analysis and to reflect on the clarity it provides. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Quantitative analysis of cell phenotype at the single-cell level
  • Interpreting phenotypic data for optimal value

View the Video Now

Meet the Speakers:

Ryan Brinkman, PhD
Professor, Medical Genetics, University of British Columbia
Distinguished Scientist, British Columbia Cancer Agency

 

 

 

Beckman

 

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS